SANTA MONICA, Calif., June 4 /PRNewswire-FirstCall/ -- Derycz Scientific, Inc. (OTC Bulletin Board: DYSC), a company
"The launch of our ePrints NRx service for the licensing and deployment of collections of scientific literature, and our recent work with leading closed-loop marketing and compliance-driven content-delivery software providers, provided compelling reasons for Reprints Desk to participate in this industry event," said Christian Gray, Sales Executive at Reprints Desk. "Reprints Desk fills an important niche in making content re-use easy and effective, while ensuring compliance with copyright, good reprint practices, and good promotional practices."
The Digital Pharma events are attended by professionals in digital marketing, relationship marketing, eBusiness and eMarketing, advertising and promotion, brand and product management, eDetailing and ePromotions, sales, and regulatory affairs, as well as information technology and information systems. Other current exhibitors and sponsors for one or both of the events include: Digitas Health, Health Central, HealthEd, Health Talker, HiLine Digital Media, ImpactRx, Interactive Logic, IOMEDIA, Medicus Life Brands, Physicians Interactive, Siren Interactive, The Encima Group, Vibrant Media, Viscira, WebMD, and Within3.
For more information about the two events, visit www.exlpharma.com.
For more information about Reprints Desk, visit www.reprintsdesk.com.
About ExL Pharma
ExL Pharma, a division of ExL Events, Inc., is an industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe and Latin America. Behind our diverse pharmaceutical event portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events designed to exceed the dynamic informational and networking needs of specific audiences and working groups.
About Reprints Desk®
Reprints Desk, Inc., is a business software and information services company that simplifies how research-intensive companies and other organizations procure, manage and share journal articles and other copyright-protected content. The company's content workflow and compliance solutions help customers effectively use peer-reviewed literature in research, regulatory submissions, and product promotions. A channel supplier for more than 100 scientific, technical, and medical (STM) publishers, Reprints Desk earned the #1 ranking in the 2008 Document Delivery Vendor Scorecard by Outsell, Inc., and currently serves companies in life sciences, energy, aerospace, industrial products, food and beverages, consumer packaged goods, information technology, legal, academia and government. Reprints Desk is a Derycz Scientific company. For more information about Reprints Desk, contact Ian Palmer at +1 (415) 533-8308.
About Derycz Scientific®
Derycz Scientific, Inc. (the "Company") develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprint Desk is an innovator in content retrieval and ePrint delivery and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for over 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters, and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, go to www.deryczscientific.com.
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. The Company assumes no obligation to update the information in this release.
SOURCE Derycz Scientific, Inc.
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Inborn errors of metabolism are genetic disorders that hamper the body''s metabolism resulting in ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All